Life took a positive turn for Carlos Campos, a 72-year-old retired machinist living in Tukwila, Wash., when he started taking Ozempic for his type 2 diabetes. His blood sugar levels improved significantly, thanks to this medication. However, his joy was short-lived when Medicare stopped covering Ozempic, causing his out-of-pocket costs to skyrocket. This led to a sudden spike in his blood sugar levels, forcing him to take more insulin along with other prescribed medications.
The rise in popularity of GLP-1 drugs like Ozempic has presented a new challenge: the complex logistics involved in managing these medications. As a result, healthcare practices are adopting a team-based approach to ensure optimal prescriptions and access for patients, especially those dealing with multiple chronic conditions and socioeconomic challenges.
Dhruv Kazi, director of the cardiac critical care unit at Beth Israel Deaconess Medical Center, emphasized the need for a comprehensive approach to maximize the benefits of these drugs. This includes addressing issues related to access, affordability, and long-term adherence.
The American Diabetes Association’s Standards of Care in Diabetes 2025 endorse a team-based approach to diabetes management, highlighting the importance of involving dietitians and nurse practitioners in patient care. This model is particularly beneficial for patients facing barriers such as food insecurity, housing instability, or employment challenges.
For Campos, the intervention of his diabetes educator, Maureen Chomko, was crucial in accessing Novo Nordisk’s patient assistance program to obtain Ozempic for free. Chomko’s expertise and assistance in navigating the application process proved invaluable in helping Campos resume his medication regimen.
Despite the effectiveness of GLP-1 drugs in managing diabetes and promoting weight loss, challenges such as medication shortages, affordability issues, and disparities in access still exist. These barriers disproportionately affect vulnerable populations, exacerbating health disparities in the United States.
The role of healthcare providers, such as nurse practitioners and dietitians, is essential in supporting patients through the initial stages of medication initiation, dose adjustments, and long-term adherence. By addressing individual needs, preferences, and barriers, these providers can improve patient outcomes and overall health.
Patients like Carol Gordon, who have struggled with weight management for years, have found success with medications like Ozempic. With the support of healthcare professionals like nurse practitioner Colleen Dawkins, Gordon has achieved sustainable weight loss and improved health outcomes. The personalized care and guidance provided by Dawkins have been instrumental in Gordon’s journey towards better health.
While challenges persist in accessing and adhering to GLP-1 medications, the collaborative efforts of healthcare teams and the integration of specialized services can enhance patient outcomes and reduce disparities in care. By addressing the unique needs of each patient and providing ongoing support, healthcare providers can empower individuals to achieve their health goals and improve their quality of life.
